What Is Octreotide (Sandostatin) Used For?

Octreotide (Sandostatin) is most commonly used for acromegaly patients under endocrine care; carcinoid / neuroendocrine tumor patients; educational reference for somatostatin pathway. A drug that shuts down the body's overproduction of growth hormone, used for conditions like acromegaly. A synthetic somatostatin analog, FDA-approved in 1988 for acromegaly, carcinoid syndrome, and VIPomas; it suppresses GH and IGF-1, the mechanistic opposite of Tesamorelin. Human evidence for Octreotide (Sandostatin) is limited, so these are the goals people pursue with it, not guaranteed outcomes.